BASF (XTRA:BAS) Could Be 4% Undervalued On Evonik Bid Talk

BASF (XTRA:BAS) is back in focus after reports that it has submitted a takeover proposal for German rival Evonik Industries, a potential reshaping of Europe’s chemicals sector that investors cannot ignore.

That takeover chatter comes after a solid run for BASF, with the share price up 12.59% year to date and supported by a 1-year total shareholder return of 23.75%. Short-term momentum has cooled, with the stock down over the past week and month, while the 90-day share price return of 5.57% still points to interest building in the story.

Scan how BASF compares to other European chemicals players by reviewing a hand-picked set of resilient industrials in the 227 resilient stocks with low risk scores that may be riding similar consolidation themes.

BASF now carries a long record, a fresh takeover bid and a share price that has already moved. The real puzzle is whether that mix still leaves the stock on offer or already fully charged.

Most Popular Narrative: 4% Undervalued

BASF last closed at €50.42, while the most followed narrative pegs fair value at about €52.55, leaving a modest gap that takeover talk now throws into sharper relief.

Portfolio streamlining and divestments focus BASF on higher-margin, resilient segments, with upcoming IPOs and expansion in agricultural and advanced technologies.

Strategic cost savings, energy sourcing diversification, and the new China site enhance competitiveness, stability, and margin potential amid evolving market and regulatory trends.

See why 106 investors see BASF as 4% undervalued.

Result: Fair Value of €52.55 (UNDERVALUED)

Still, the BASF narrative runs into real friction if European demand stays weak, or if portfolio sales and the planned Agricultural Solutions IPO slip or disappoint.

Find out about the key risks to this BASF narrative.

Next Steps

If this BASF takeover story leaves you torn between risk and reward, move quickly to test the numbers and sentiment yourself by weighing up the 3 key rewards and 3 important warning signs.

Looking for more BASF-sized investment ideas?

Do not stop with BASF. Put a shortlist of fresh opportunities on your radar today so you are not catching up when the next move hits.

• Target resilient value plays that combine quality fundamentals with room for a rerating by scanning the 182 high quality undervalued stocks.
• Build a stream of potential income ideas by reviewing the 162 dividend fortresses that could help anchor a return-focused portfolio.
• Prioritise financial strength first and filter for sturdier balance sheets using the list of solid balance sheet and fundamentals (202 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com